Skip to main content
47°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
October 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GSK
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Submits New Drug Application to FDA for TNX-102 SL for Fibromyalgia Treatment
October 16, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
October 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVAX
Bitcoin Rises While Ethereum, Dogecoin Stay Flat Amid Stock Reversal; ASML Struggles, Nvidia and AMD Recover; Stellantis Recalls 21K Hybrid SUVs Over Brake Pedal Issue - Top Headlines Today While US Slept
October 16, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
AMD
NVDA
SPY
CCHR Wants Increased Consumer Awareness About "Prescriptions for Violence"
October 14, 2024
Via
PRLog
Exposures
Product Safety
Tickers
EB
The Heart and Soul of Park Slope: Alan Davidoff
October 09, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
October 16, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
HIMS
LLY
NVO
Stellantis Recalls Nearly 21K Plug-In Hybrid SUVs In US Over Concerns Of Brake Pedal Disengaging
October 16, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
October 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVCR
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
October 16, 2024
Via
The Motley Fool
Exposures
Product Safety
Tickers
LLY
Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act
October 15, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
Cher Wolf Design Group Announces Its "Hosting the Holidays!" Theme for 2024
October 16, 2024
Via
PRLog
Topics
Product Recall
Exposures
Legal
Product Safety
Nano Hearing Aids' CEO Targets Key Global Markets With Ambitious Worldwide Tour
October 15, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
October 15, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BMY
MRK
NVCR
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance for Pivotal Phase 3 Alzheimer’s Trial, Launch Set for Early 2025
October 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
ANVS
Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports
October 15, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BAX
Las Vegas Eye Institute Clarifies Ideal Age for LASIK Surgery, Emphasizes Importance of Vision Stability
October 15, 2024
Via
Press Advantage
Exposures
Product Safety
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
October 14, 2024
Via
Investor's Business Daily
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
HIMS
LLY
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
October 14, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
FDA To Reassess Ban On Cheaper, Compounded Versions of Eli Lilly Weight Loss Drugs
October 14, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
October 14, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
PFE
SGMO
Listeria Scare Prompts Albertsons To Recall Certain Ready-To-Eat Meals In Multiple States
October 14, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ACI
FXG
Where Does Hims & Hers Stock Go From Here?
October 12, 2024
Via
The Motley Fool
Exposures
Product Safety
Tickers
CVS
HIMS
WBA
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
October 10, 2024
Via
Newsfile
Exposures
Product Safety
Tickers
ELTP
Introducing Garrett Shultz’s New Single: “You Over Me”
October 10, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
October 10, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
NVO
The Future of Medical Devices: Two Strong Buys You Can't Miss
October 10, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
INFU
TCMD
BioMedNewsBreaks — Oragenics, Inc. (NYSE American: OGEN) Reports on Lead Candidate Drug Development, ‘Urgency’ to Advance First-in-Class Concussion Treatment
October 09, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
OGEN
Travere Therapeutics Hits 14-Month High On A Promising FDA 'Pivot' In Kidney Disease
October 09, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
TVTX
What's Going With WeightWatchers Stock On Wednesday?
October 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
NVO
WW
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.